![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CODEXIS INITIATES DIRECT SALES OF GENERIC PHARMACEUTICAL INTERMEDIATES
CODEXIS INITIATES DIRECT SALES OF GENERIC PHARMACEUTICAL INTERMEDIATES
Codexis, Inc., a privately held biotechnology company, announced the company has expanded into direct sales of pharmaceutical intermediates with receipt of the first commercial orders from leading generics manufacturers for ATS-8, the key chemical intermediate in atorvastatin. Atorvastatin is the active ingredient in the world's largest-selling drug for lowering cholesterol. The announcement was made in conjunction with the 2006 CPHI (Convention of Pharmaceutical Ingredients and Intermediates) annual conference in Paris. PR Newswire (http://sev.prnewswire.com/medical-pharmaceuticals/20061003/SFTU00503102006-1.html) (http://allafrica.com/stories/200610010095.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct